Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.
The Scientist
Most Recent
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.
Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.
How plants pass defenses to offspring through a complex molecular network
Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.
Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.
A NJ senator and BIO are beating the drum to reinstitute a law that would channel millions into small life science companies around the country.
The diversity of microbes in the great outdoors may protect against inflammatory disorders.
A former Sanofi research scientist is sentenced to 18 months in prison for stealing trade secrets.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
